We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (GIPI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01363206
Recruitment Status : Unknown
Verified March 2014 by Lynn E. Spitler, MD, Northern California Melanoma Center.
Recruitment status was:  Active, not recruiting
First Posted : June 1, 2011
Last Update Posted : March 10, 2014
Sponsor:
Collaborator:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2014
  Estimated Study Completion Date : May 2015